ATyr Pharma announces formation of therapeutic advisory board
aTyr Pharma, the Physiocrine therapeutics company, today announced the formation of a therapeutic advisory board.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the formation of a scientific advisory board in major depressive disorder.